MARKET

EYES

EYES

Second Sight Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.220
-0.210
-6.12%
Closed 19:50 09/20 EDT
OPEN
3.370
PREV CLOSE
3.430
HIGH
3.425
LOW
3.160
VOLUME
1.26M
TURNOVER
--
52 WEEK HIGH
20.00
52 WEEK LOW
0.7200
MARKET CAP
126.90M
P/E (TTM)
-9.8803
1D
5D
1M
3M
1Y
5Y
Avoid These 3 Stocks
StockNews.com · 08/24 09:31
Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announces that the Company re...
Business Wire · 08/11 10:00
Second Sight Obtains New NIH Grant Supplement for Visual Neuroprostheses Study
MT Newswires · 08/11 07:00
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Benzinga · 07/23 20:50
CLOV Stock: What Reddit Investors Are Saying About Clover Health Today as Shares Climb
Investor Place · 07/22 15:31
MRIN Stock: 10 Things for Marin Software Investors to Know About the Popular Meme Stock Today
Investor Place · 07/22 14:53
EYES Stock: The Artificial Vision News That Has Investors Looking at Second Sight
Investor Place · 07/22 13:41
SOS, ITRM and PSTV among premarket gainers
India Globalization Capital (IGC) +128% announces issuance of Patent for the treatment of Alzheimer’s disease using THCPainReform (PRFX) +51%.ImmunoPrecise Antibodies (IPA) +41% highlights new data from TATX-03 SARS-CoV-2 Delta studySequential Brands (SQBG...
Seekingalpha · 07/22 13:03
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EYES. Analyze the recent business situations of Second Sight Med through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EYES stock price target is 2.500 with a high estimate of 2.500 and a low estimate of 2.500.
EPS
Institutional Holdings
Institutions: 76
Institutional Holdings: 4.83M
% Owned: 12.26%
Shares Outstanding: 39.41M
TypeInstitutionsShares
Increased
9
894.99K
New
22
1.08M
Decreased
7
1.41M
Sold Out
7
33.93K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.45%
Healthcare Equipment & Supplies
-1.59%
Key Executives
Chairman/Director
Gregg Williams
Chief Executive Officer
Scott Dunbar
Vice President - Operations
Edward Randolph
Other
Stephen Okland
Director
Alexandra Larson
Director
Jonathan McGuire
Independent Director
Dean Baker
Independent Director
Aaron Mendelsohn
Independent Director
Matthew Pfeffer
No Data
  • All
  • Financials
  • Insiders
More
About EYES
Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing implantable visual prosthetics devices that restore vision to blind individuals. The Company manufactures neuromodulation devices for blindness and engaged in developing new technologies to treat sight-impaired individuals. Its approved product, the Argus II Retinal Prosthesis System (Argus II), treats outer retinal degenerations, such as retinitis pigmentosa (RP). It is engaged in developing the Orion Visual Cortical Prosthesis System (Orion), an implanted cortical stimulation device, which provides artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion works by converting video images captured by a miniature camera housed in a user’s glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes.

Webull offers kinds of Second Sight Medical Products Inc stock information, including NASDAQ:EYES real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EYES stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EYES stock methods without spending real money on the virtual paper trading platform.